Analysis of survival data in gliomas in the Rembrandt (REpository for Molecular BRAin Neoplasia DaTa) dataset showed that patients with increased levels of ECT2 mRNA have a lower survival than those with intermediate levels (Fig. 3). The gene discussed is ECT2; the disease is glioma.